Grauer & Weil (India) Limited (GRAUWEIL.NS)
Mumbai, IN
Grauer & Weil (India) Limited, an enterprise established in 1957 and headquartered in Mumbai, India, is a prominent manufacturer and distributor of chemical and engineering products. The company's reach extends both domestically across India and internationally, exporting its goods to approximately 50 countries worldwide. Its operations are divided into three core divisions: Surface Finishing, Engineering, and the Mall segment. Within its extensive chemical product line, Grauer & Weil provides a broad spectrum of offerings. These include various pre-treatment solutions, diverse plating chemicals (covering general, conversion, PCB and electronics, precious metal, and continuous plating applications), lacquers, chemical intermediates, strippers, protective post-treatment agents, blackening chemicals, basic industrial chemicals, zinc flake coatings, as well as specialized electroplating, phosphating, and anodizing compounds. The company also supplies a comprehensive array of lubricants. This range features rust preventives, numerous types of industrial oils (such as cutting, hydraulic, lubricating, spindle, circulating, MS and steel wire drawing, gear, vanish and deep draw, EDM, heat treatment, tube drawing, wire drawing, glass grinding, chain, and blanking oils), and cleaning agents. In its engineering capacity, Grauer & Weil specializes in delivering customized turnkey plants and their essential components. These solutions are designed for surface finishing processes, effluent and wastewater treatment systems, and other general engineering applications. Furthermore, the company furnishes various protective coatings, including formulations for marine environments, industrial protection, pipe coatings, architectural finishes, and automotive and general industrial applications. Beyond its industrial ventures, Grauer & Weil also operates a shopping mall.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +10.16% | +17.02% | +2.85% | +10.06% | +10.06% | +10.06% | +10.06% | +26.87% | +136.06% | +136.06% | +136.06% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals - Specialty: +4.7%+5.0% ★ Q1'26: +0.9% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+4.3% Q1'26: +91.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+8.8% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+14.2% ★ Q1'26: +15.0% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+20.0% ★ Q1'26: +25.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: +0.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.08× ★ Q1'26: 0.06× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2025 actual |
|---|---|
| Revenue |
11.34B
est: 13.80B (-17.8%)
|
| EBITDA |
2.35B
est: 3.38B (-30.5%)
|
| EBIT |
2.12B
est: 3.27B (-35.2%)
|
| Net Income |
1.57B
est: 1.99B (-21.1%)
|
| SGA |
260.45M
est: 535.27M (-51.3%)
|
| EPS |
3.47
est: 4.40 (-21.1%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Nirajkumar Umeshkumar More | MD & Director | 24M | male |
| Yogesh Ramchand Samat | Director of Operations & Whole-Time Director | 20M | male |
| Umeshkumar N. More | Executive Chairman | 15M | male |
| Rohitkumar R. More | Whole Time Director | 9M | male |
| Pallavi N. More | President | 8M | female |
| Gurinder Singh Gulati | Chief Financial Officer & President of Commercial | 2M | male |
| Chintan K. Gandhi | Compliance Officer & Company Secretary | 2M | male |
| Shashikant Keshav Sakhalkar | Chief Corporate Officer | 528.0K | male |
| Manish Mehra | Chief Operating Officer | — | male |
| H. Charna | Senior President of Engineering | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GRAUWEIL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
